Sight Diagnostics Stock / Medical DevicesFounded: 2012

Sight Diagnostics is an Israeli medical devices startup that’s using AI technology to speed up blood testing. Its mission is to change the way blood testing is done by providing fast, convenient and accurate diagnostics in a compact platform designed for use in any clinical setting, overseen by CLIA certified lab. Developed over almost a decade of research, its technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science. Its first product, Parasight™, has diagnosed malaria in nearly 1 million tests across 24 countries. Sight OLO®, their latest blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade CBC results in minutes.

Register To Buy and Sell Shares

For more details on financing and valuation for Sight Diagnostics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Sight Diagnostics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Sight Diagnostics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Sight Diagnostics investors also invested in these private companies


Management Team

Daniel Levner
Amir Ben Shitrit
Chief Operating Officer
Ron Melts
US General Manager
Eran Rubens
Chief Product Officer
Nitsan Maayan-Rabinowich
Chief of Staff

Frequently Asked Questions About Sight Diagnostics’ Stock

Can you buy Sight Diagnostics’ stock?
Sight Diagnostics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Sight Diagnostics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Sight Diagnostics’ stock?
Yes, you can sell stock of a private company like Sight Diagnostics. Forge can help you sell your Sight Diagnostics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Sight Diagnostics’ stock price?
Sight Diagnostics is a privately held company and therefore does not have a public stock price. However, you may access Sight Diagnostics’ private market stock price with Forge Data.
What is Sight Diagnostics’ stock ticker symbol?
Sight Diagnostics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.